Kepler Capital Markets set a €102.00 ($121.43) target price on Bayer AG (FRA:BAYN) in a research report released on Monday morning. The brokerage currently has a neutral rating on the healthcare company’s stock.
Several other research firms also recently issued reports on BAYN. UBS AG set a €125.00 ($148.81) price target on Bayer AG and gave the stock a buy rating in a research note on Wednesday, June 7th. Sanford C. Bernstein set a €128.00 ($152.38) price target on Bayer AG and gave the stock a buy rating in a research note on Tuesday, June 6th. Jefferies Group LLC set a €145.00 ($172.62) price target on Bayer AG and gave the stock a buy rating in a research note on Monday, May 29th. DZ Bank AG reaffirmed a neutral rating on shares of Bayer AG in a research note on Saturday, May 20th. Finally, Commerzbank Ag set a €126.00 ($150.00) price target on Bayer AG and gave the stock a buy rating in a research note on Monday, May 8th. Nine investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The stock has an average rating of Buy and an average target price of €119.64 ($142.42).
Shares of Bayer AG (FRA:BAYN) opened at 107.22 on Monday. The stock has a 50 day moving average of €108.88 and a 200-day moving average of €110.84. The stock has a market capitalization of €93.51 billion and a PE ratio of 18.55. Bayer AG has a 52 week low of €85.72 and a 52 week high of €123.82.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2017/08/31/kepler-capital-markets-analysts-give-bayer-ag-bayn-a-102-00-price-target.html.
Bayer AG Company Profile
Receive News & Ratings for Bayer AG Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bayer AG and related companies with MarketBeat.com’s FREE daily email newsletter.